相关实验视频
Updated: Jun 23, 2026

08:04
Murine Fetal Echocardiography
Published on: February 15, 2013
17.3K
怀孕晚期心脏不分化的多形肉瘤病例:一个病例报告
Junlei Zhang1, Xiaoyan Lin2, Yuanhui Yang1
1Medical Integration and Practice Center, Shandong University, Jinan, Shandong, China.
SAGE open medical case reports
|May 1, 2024
概括
恶性心脏瘤虽然很少见,但需要及时诊断和干预. 新辅助疗法,可能包括放射疗法,可以改善患有这些侵袭性心脏瘤的患者的生存率.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 心脏瘤很罕见,大多数是良性的.
- 恶性心脏瘤虽然不常见,但由于其高恶性,需要提高临床和病理诊断意识.
- 确定加强无复发和整体存活的干预措施对于恶性心脏瘤至关重要.
研究的目的:
- 在怀孕的患者中报告一种罕见的心脏不分化形肉瘤病例.
- 讨论与恶性心脏瘤相关的诊断和治疗挑战.
- 探索潜在的治疗策略,以改善患者的生存率.
主要方法:
- 在怀孕的患者中切除左心房质量的手术.
- 手术后的观察和文献审查.
- 对恶性心脏瘤治疗结果的分析.
主要成果:
- 一名42岁的孕妇出现了心脏不分化的多形肉瘤.
- 在剖腹产后立即进行左心房质量的外科切除.
- 瘤复发发生在手术后6个月,没有额外的治疗.
- 文献综述表明,放射治疗可能会在复发后延长存活时间.
结论:
- 早期诊断和干预对于恶性心脏瘤至关重要.
- 新辅助疗法,如放射治疗,可能有助于改善复发性恶性心脏瘤患者的生存率.
- 需要进一步的研究,以建立这些罕见恶性瘤的最佳治疗方案.
更多相关视频
05:16Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
3.4K
11:27A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
6.2K
相关概念视频
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...